A Study for PMS of AZL-M in the Treatment of Adult Participants With Essential Hypertension in South Korea

NCT04470817 · clinicaltrials.gov ↗

COMPLETED

Status

3438

Enrollment

INDUSTRY

Sponsor class

Conditions

Essential Hypertension

Interventions

DRUG: Azilsartan Medoxomil

Sponsor

Celltrion Pharm, Inc.